The pharmacokinetics of α-human atrial natriuretic polypeptide in healthy subjects

K. Nakao, A. Sugawara, N. Morii, M. Sakamoto, T. Yamada, H. Itoh, S. Shiono, Y. Saito, K. Nishimura, T. Ban, K. Kangawa, H. Matsuo, H. Imura

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

We have analysed the pharmacokinetics of α-human atrial natriuretic polypeptide (α-hANP) in healthy subjects, using a two-compartment open model following bolus intravenous injection. The plasma half-times for the fast and slow components were 1.7±0.07 min and 13.3±1.69 min respectively. V1 (the volume of the central compartment), Vz (volume of distribution) and Vss (volume of distribution at steady-state) were 5370±855 ml (89.5±14.3 ml·kg-1), 32000±4620 ml (533±77.0 ml·kg-1), and 11900±1530 ml (198±25.5 ml·kg-1) respectively. The mean plasma clearance was 1520±121 ml·min-1 (25.4±2.0 ml·min-1·kg-1.

Original languageEnglish
Pages (from-to)101-103
Number of pages3
JournalEuropean Journal of Clinical Pharmacology
Volume31
Issue number1
DOIs
Publication statusPublished - 1986 Jan 1
Externally publishedYes

    Fingerprint

Keywords

  • atrial natriuretic polypeptide
  • pharmacokinetics
  • radioimmunassay
  • α-hANP

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Nakao, K., Sugawara, A., Morii, N., Sakamoto, M., Yamada, T., Itoh, H., Shiono, S., Saito, Y., Nishimura, K., Ban, T., Kangawa, K., Matsuo, H., & Imura, H. (1986). The pharmacokinetics of α-human atrial natriuretic polypeptide in healthy subjects. European Journal of Clinical Pharmacology, 31(1), 101-103. https://doi.org/10.1007/BF00870995